Related Experiment Video
Updated: Feb 13, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Noninvasive pulmonary arterial pressure estimation using a logistic-based systolic model.
Hyunsuk Frank Roh1, Jung Mogg Kim2
1Department of Biomedical Science, Hanyang University College of Medicine and Graduate School of Biomedical Science and Engineering, Seoul, South Korea.
A new logistic-based model establishes a hemodynamic relationship between pulmonary artery pressure (PAP) and pulmonary acceleration time (PAcT). This model offers an accurate method for estimating PAP using transthoracic echocardiography.
Area of Science:
- Cardiovascular Physiology
- Medical Imaging
- Biomedical Engineering
Background:
- Pulmonary artery pressure (PAP) and pulmonary acceleration time (PAcT) have a known hemodynamic relationship, but it has not been explicitly modeled.
- Transthoracic echocardiography is a non-invasive imaging technique used to assess cardiac function and pressures.
Purpose of the Study:
- To develop and validate a logistic-based systolic model to explicitly define the hemodynamic relationship between systolic PAP and PAcT.
- To derive a novel equation for estimating systolic PAP based on PAcT measurements from transthoracic echocardiography.
Main Methods:
- A modified logistic-based systolic model was employed for pulmonary circulation.
- The model was used to deduce an equation relating systolic PAP and PAcT.
- The derived equation was statistically validated against existing PAP estimation methods using published data.
Main Results:
- The logistic-based PAP estimation equation demonstrated accuracy comparable to existing methods for mean PAP estimation.
- The modified model successfully reflected pulmonary circulation physiology and its harmony with systemic circulation.
- The model provides a logical basis for the systolic PAP and PAcT relationship.
Conclusions:
- The developed logistic-based PAP estimation equation shows promise for clinical application.
- Further clinical studies are required to validate the equation using direct systolic PAP and PAcT measurements.
- The model enhances understanding of pulmonary hemodynamics and its non-invasive assessment.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Assessment of blood pressure in brachial artery(two-step method)
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

